AARON DUBRINSKY: Open Payments
NPI 1932237245 · VERO BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,063 in 28 payments from 9 companies in 2025. Trend: 2023 $47 · 2024 $1,284 · 2025 $1,063
Food & beverage: $1,063
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 8 | $363 |
| Teva Pharmaceuticals USA, Inc. | 4 | $211 |
| Otsuka America Pharmaceutical, Inc. | 4 | $166 |
| Janssen Pharmaceuticals, Inc | 3 | $153 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $61 |
| Vanda Pharmaceuticals Inc. | 2 | $44 |
| ABBVIE INC. | 2 | $36 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
| Lundbeck LLC | 1 | $14 |
Products named: LYBALVI, ABILIFY MAINTENA, UZEDY, SPRAVATO, AUSTEDO XR, CAPLYTA, ARISTADA, FANAPT.
Industry payments across FL — which companies pay providers there.
